FOXHOUSE LIMITED

Company number 13478232 ·

Liquidation

This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.

FOXHOUSE LIMITED - Analysis Report

Company Number: 13478232

Analysis Date: 2025-07-20 19:16 UTC

Financial Health Assessment Report for FOXHOUSE LIMITED


1. Financial Health Score: B

Explanation:
FOXHOUSE LIMITED demonstrates solid financial footing with positive net assets and working capital, indicating a generally healthy balance sheet for a micro-entity of its size. The company has shown growth in net assets from £72,140 in 2022 to £104,315 in 2023, which is a positive sign of financial strengthening. However, some caution is warranted due to a significant reduction in current assets and an increase in fixed assets, alongside persistent current liabilities. This score reflects a stable but cautiously optimistic outlook.


2. Key Vital Signs

Metric 2023 Value (£) 2022 Value (£) Interpretation
Fixed Assets 63,777 18,109 Significant increase suggests capital investment or asset acquisition. Healthy if assets are productive.
Current Assets 158,353 237,732 Decreased by ~33%, a symptom that liquidity has tightened. Important to monitor cash and receivables closely.
Current Liabilities 112,537 182,501 Decreased, which is positive, reducing short-term debt pressure.
Net Current Assets 45,816 55,231 Positive working capital confirms the company can cover short-term obligations; a healthy cash flow sign.
Total Assets less Current Liabilities 109,593 73,340 Increased significantly, suggesting improved overall financial strength.
Net Assets / Shareholders' Funds 104,315 72,140 Positive equity growth indicates retained profits or capital injections. Reflects financial resilience.
Staff Numbers 4 4 Stable workforce, likely supporting consistent operational capacity.

Additional Notes:

  • Share capital is minimal (£100), typical for a micro-entity, with the bulk of equity likely from retained earnings.
  • No overdue filings, indicating good compliance health.
  • Directors are experienced with no reported disqualifications, supporting good governance.

3. Diagnosis: Financial Health Insights

  • Healthy Cash Flow and Liquidity:
    The company maintains positive net current assets (£45,816), indicating it can meet short-term liabilities without distress. This "healthy pulse" suggests operational liquidity is sound, though the decrease in current assets points to less cash or receivables available, which should be monitored to avoid future liquidity strain.

  • Asset Base and Capital Investment:
    The fixed assets nearly quadrupled in value from £18,109 to £63,777. This is like a patient building muscle mass—capital investments could improve long-term productivity and competitive positioning but also tie up cash. The company must ensure these assets generate returns to avoid "asset fatigue" or financial rigidity.

  • Equity and Financial Stability:
    The increase in net assets and shareholders’ funds reflects retained profits or capital injections, akin to a strengthened immune system. This provides a buffer against economic shocks and supports sustainable growth.

  • Liabilities:
    Current liabilities decreased, which reduces the risk of short-term financial distress. The presence of a small amount of long-term liabilities (£3,386 in 2023) is manageable but worth tracking for repayment schedules.

  • Operational Scale and Activity:
    The company remains a micro entity with consistent staffing, suggesting stable but modest operational scale. This "steady heartbeat" implies manageable complexity and overheads.


4. Recommendations: Steps to Enhance Financial Wellness

  1. Monitor Liquidity Metrics Closely:
    Given the decline in current assets, implement tighter cash flow management and accounts receivable controls to avoid liquidity "symptoms" like cash shortages.

  2. Evaluate Fixed Asset Utilization:
    Assess the productivity and return on new fixed assets. Ensure they contribute to revenue growth or cost efficiencies to justify the increased investment.

  3. Maintain Working Capital Discipline:
    Continue to manage current liabilities prudently to preserve positive net current assets, ensuring the company can respond flexibly to operational needs or market changes.

  4. Plan for Sustainable Growth:
    With a healthy equity base, consider strategic initiatives such as diversifying services or investing in marketing, but balance growth ambitions against the company's micro-entity scale.

  5. Governance and Compliance:
    Maintain timely filings and strong director oversight to avoid regulatory risks that could act as financial "infections."

  6. Scenario Planning:
    Prepare contingency plans for cash flow disruptions, especially considering the company’s relatively young age (incorporated 2021) and evolving market conditions.


Perspective: Financial Health Diagnostician · Model: gpt-4.1-mini · Generated 20 July 2025

Sign in to generate a free AI analysis of this company — no password needed, just an email link.